Holocene Advisors
GPCR icon

Holocene Advisors’s Structure Therapeutics GPCR Stock Holding History

Holocene Advisors’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.66M Buy
+159,009
New +$10.9M 0.02% 340
2023
Q4 		– Sell
-281,291
Closed -$14.2M – 752
2023
Q3 		$14.2M Buy
+281,291
New +$9.07M 0.06% 232

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Holocene Advisors's GPCR Position: Q1 2026 in Review

Holocene Advisors opened a new position in Structure Therapeutics (GPCR) in Q1 2026: 159,009 shares worth $7.66M. The stake represents 0.02% of the portfolio and ranks #340 among its holdings. This is a return to the name: Holocene Advisors previously reported a position in GPCR as recently as Q3 2023.

Holocene Advisors first reported a position in GPCR in Q3 2023 and has held it in 2 quarters since. The position peaked at $14.2M in Q3 2023. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Holocene Advisors held 159,009 shares of Structure Therapeutics worth $7.66M as of Q1 2026.
  • Structure Therapeutics was a new Holocene Advisors position in Q1 2026.
  • Structure Therapeutics made up 0.02% of Holocene Advisors's portfolio in Q1 2026, its #340 holding.
  • Holocene Advisors first reported a position in Structure Therapeutics in Q3 2023 and has held it in 2 quarters since.
  • Holocene Advisors's Structure Therapeutics position peaked at $14.2M in Q3 2023.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.